Carlsmed, Inc.
CARL
$9.99
-$0.87-8.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -82.48% | -9.13% | -7.79% | -5.18% | |
| Total Depreciation and Amortization | 164.86% | 148.48% | 74.29% | 0.00% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 78.86% | 100.13% | 190.98% | 20.87% | |
| Change in Net Operating Assets | 534.12% | -176.61% | -237.52% | -22.46% | |
| Cash from Operations | -26.60% | -11.60% | -12.31% | -10.01% | |
| Capital Expenditure | -19.67% | -205.77% | -1,823.53% | -66.00% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | -39,621.31% | -559.62% | -3,852.94% | -376.00% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 200.00% | 2,336,550.00% | 209.09% | 1,141.67% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -100.00% | -- | -69.04% | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -15,300.00% | -2,353.33% | |
| Cash from Financing | 43.14% | 551.41% | -136.65% | -69.61% | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -585.52% | 1,201.67% | -6,203.80% | -89.34% | |